Skip to main content
. 2010 May;26(5):249–258. doi: 10.1016/s0828-282x(10)70379-2
Co-Chairs: S Tobe, M Lebel
Central Review Committee: B Hemmelgarn (Chair), D Hackam, M Hill, N Khan, J Mahon, R Padwal, R Quinn
Subgroups
  Ambulatory Blood Pressure Monitoring: M Myers (Chair), M Dawes
  Lifestyle Modification in Hypertension: R Touyz (Chair), N Campbell, L Trudeau, S Bacon, R Petrella
  Adherence Strategies for Patients: T Campbell (Chair), R Feldman, A Milot, J Stone, D Drouin
  Accurate Measurement of Blood Pressure: L Cloutier (Chair), K Mann, M Lamarre-Cliche
  Cardiovascular Risk Assessment: S Grover (Chair), G Tremblay, A Milot
  Pharmacotherapy for Hypertensive Patients with Cardiovascular Disease: S Rabkin (Chair), M Arnold, G Moe, J Howlett
  Echocardiography: G Honos (Chair)
  Pharmacotherapy for Hypertensive Patients Without Compelling Indications: R Herman (Chair), P Hamet, G Fodor, G Dresser, G Carruthers, G Pylypchuk, E Burgess
  Endocrinological Forms of Hypertension: EL Schiffrin (Chair)
  Renal and Renovascular Hypertension: M Ruzicka (Chair), K Burns, S Tobe, M Vallée, R Prasad, M Lebel
  Follow-up on Patients with Hypertension: P Bolli (Chair), G Tremblay
  Routine Laboratory Tests: T Wilson (Chair), B Penner
  Hypertension & Diabetes: P Larochelle (Chair), R Gilbert, L Leiter, C Jones, R Ogilvie, S Tobe, V Woo
  Self Measurement of Blood Pressure: D McKay (Chair), A Chockalingam, D McLean
  Vascular Protection: R Feldman (Chair), EL Schiffrin, R Hegele, P McFarlane
  Pharmacotherapy for Hypertensive Patients with Cerebrovascular Disease: P Lindsay (Chair), J-M Boulanger, M Sharma